Randomized Assessment of the Safety and Efficacy of Intra-Arterial Infusion of Autologous Stem Cells in Subacute Ischemic Stroke.

Vikas Bhatia Vivek Gupta Dheeraj Khurana Ratti Ram Sharma N Khandelwal

Published in: AJNR. American journal of neuroradiology (2018)

Intra-arterial infusion of stem cells can be carried out safely in the subacute stage of ischemic stroke. Improved clinical outcomes were observed with intra-arterial stem cell therapy; however, studies with larger cohorts are needed to validate the results.

Keyphrases

cell therapy
stem cells
mesenchymal stem cells
low dose
atrial fibrillation
open label
double blind
phase iii
randomized controlled trial
clinical trial
phase ii
study protocol
platelet rich plasma
clinical evaluation